Recursion Pharmaceuticals
clinical orally small molecule inhibitor disease state impact blocks mutation induced signaling are | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
109 of 143
Related slides by other companies
Blackwells Capital
Activist
January 2022
impact way psi oes a | Blackwells Capital
a16z
Market
April 2023
the state of index is interactive you can manipulate the weights and thresholds according to your preferences our default values represent just one many views market determine how much impact each category has on overall calculation determine minimum value for a category start contributing | a16z
Alkermes
Investor Day
March 2021
leveraging alkermes molecular design capabilities to target dysfunction in narcolepsy in complex with peptide agonist working to develop a best in class molecule designed to mimic potency and performance of endogenous peptide agonist with orally therapy possess favorable half life have profile that mirrors natural wake cycle avoid safety risks associated with stimulant medications pharmacodynamic figure adapted from hong nature communications | Alkermes
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io